Top story

The new WHO report “Medicines reimbursement policies in Europe” examines the various policies that increase access to affordable medicines. Based on direct data collection from 45 of the 53 countries in the WHO European Region, it showcases diverse national practices and aims to identify key aspects of policy frameworks that protect vulnerable groups from unaffordable out-of-pocket payments for medicines.

News

• How to ensure access to essential medicines for all? New WHO report reviews medicines reimbursement policies in Europe 18-07-2018
• Robust regulatory framework in Kyrgyzstan will improve financial access to medicines 04-07-2018
• WHO e-Pocket book app: helping save children’s lives in Kyrgyzstan and Russian Federation 25-06-2018

Events

• Third summer school on pharmaceutical pricing and reimbursement policies 23–27 July 2018, Vienna, Austria

Medicines

WHO/Europe works with countries to help them ensure that people have equitable access to affordable medicines of assured quality, and that medicine will be prescribed and used appropriately.

Health technologies

Technology is used in all types of health facilities, plays a major role in contemporary health care systems and contributes directly to the quality of patient care.

Videos

The challenge to Austria’s social security system of financing new and expensive medicines

Country work

National policies on medicines cover all aspects, including manufacturing, patenting, prescribing, regulation, taxation and pricing.

Publications

Policy areas

• Policies and resolutions
• Regulation and quality
• Health technology assessment
• Pricing and reimbursement
• Responsible use of medicines
• Biosimilars